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Abstract
Background: The prevalence of type 2 diabetes mellitus is increasing substantially worldwide, leading to serious
economic effects, complications and deaths. This study evaluated the effectiveness of an empowerment program
providing support for psychosocial, behavioral, and clinical aspects of diabetes to help Brazilian users of public
health services obtain metabolic control of this condition.
Methods: In this cluster randomized trial, participants aged 30–80 diagnosed with type 2 diabetes were recruited
from ten Brazilian public health units in 2014 and 2015. Five units were randomly assigned to receive the empowerment
program based on a behavior change protocol, and five continued to receive only conventional treatment. The primary
outcome was the biochemical and anthropometric parameters, and the secondary outcomes were self-care, attitude,
knowledge and empowerment related to diabetes. The effect of the experiment was defined as the percentage
variation between the values at the initial and final periods. To evaluate this effect and to compare it in the two
groups, tests were used for paired and independent samples, respectively.
Results: There were 238 participants: 127 and 111 in the intervention and control group, respectively. For glycated
hemoglobin, the mean effect in the control and intervention groups was 3.93 and −5.13, respectively (p < 0.001). Levels
of glycated hemoglobin and other metabolic indicators, as well as the most part of the secondary outcomes showed a
significant difference in the experimental group compared to the control group.
Conclusions: The empowerment program improved metabolic control of type 2 diabetes in Brazilian users.
Trial registration: NCT02132338 - April 22, 2014.
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Background
Diabetes mellitus has a high prevalence worldwide, lead-
ing to problems such as increased mortality and health
costs [1, 2]. There were 387 million cases of diabetes in
2014, and 415 million in 2015. It is predicted that there
will be 642 million cases in adults between 20 and
79 years of age by 2040. In 2015 alone, five million died
from diabetes [3, 4]. Brazil is the country with the
fourth-largest number of people with diabetes: 14.3
million; 130.000 people died from this condition in
Brazil, more than in any other country in Central and
South America, and more than half of all diabetes deaths
in the region in 2013 [4].
Brazil has a public policy of following up users with DM
through the primary healthcare service [5]. The Ministry of
Health implemented the DM characterization measures
through a national study that traced the health status of
users as well as expansion of the public health teams and
their training for the care of several chronic conditions and
interventions to change specific behavior for DM [5, 6].
To reduce the impact of diabetes in Brazil, proactive,
integrative, interdisciplinary and continuous educational
programs need to be developed, providing individualized
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care for each person based on the context of their life
[5]. Traditional methods of care alone, which utilize pre-
scriptive actions the patient is expected to adhere to in
order to control diabetes, are unable to stop the progres-
sion of this condition [6, 7].
Educational programs based on empowerment use a
participatory process that allows people with diabetes to
be responsible for their own condition, sharing that re-
sponsibility with health care professionals, and having
their actions in care management acknowledged [8, 9].
Patients who indicate they can make their own decisions
are more likely to take responsibility for their own dia-
betes care [5, 10], and many studies around the world
have addressed this approach [8, 11–14].
From this perspective, an empowerment program based
on dialog, exchange, and Freirean theories was developed
in a Brazilian city [15]; this program involved behavioral,
psychosocial, and clinical aspects related to diabetes in an
effort to control this condition. Thus, the objective of this
study was to evaluate the effectiveness of an empower-
ment program for metabolic control aimed at Brazilian
patients in the public health system with type 2 diabetes.
Methods
This randomized cluster trial involved public health users
with type 2 diabetes who received services from 10 pri-
mary care units in one Brazilian town from December
2014 to December 2015. The study was approved by the
Research Ethics Committee of the Federal University of
Minas Gerais, Brasil, under Process 426.968/2013, and all
participants signed an informed consent agreement. The
study is listed in the International Clinical Trials as
NCT02132338 and in the Brazilian registry as RBR-92j38t.
Participants
The study involved users of public health services who
met the eligibility criteria for random distribution into the
study groups. The following criteria were required: having
type 2 diabetes, being literate, aged between 30 and
80 years, having no serious complications, being open to
communication and cooperation, agreeing to attend group
meetings at the health units and to receive visits at home,
providing information for telephone contact, and being
sufficiently independent to perform self-care activities.
Based on a study involving the population of users
with diabetes in the town [16] and data from a previous
study [17] by the research group, the sample size was
calculated considering the cluster effect [18]. The calcu-
lation has resulted in 100 participants for each group
(control and intervention group). Using R software (R
Core Team, 2015), various combinations of the ten units
were composed and allocated to two groups of five units
each. One of the combinations that satisfied the homo-
geneity criteria for these groups with regard to age,
glycated hemoglobin, and education level was randomly
selected. Next, one of the groups was randomly allocated
to receive the intervention (IG) and the other was allo-
cated as the control group (CG).
Sample size calculation
To calculate the unadjusted sample size (m) in each group,
which does not consider the clustering effect, we have
modified the expression (2) reported by Campbell et al.
(2004) [18] considering a finite population as follows:
m ¼ ð
N
2= Þ4 z1− α=2ð Þþzϖð Þ2
ðN 2−1= Þd2þ4 z1− α=2ð Þþzϖð Þ2; where d is the anticipated
standardized effect size for the main outcome [glycosyl-
ated hemoglobin (HbA1c), %], i.e., the minimum differ-
ence to be detected between two groups and is termed
as standard deviation; α is the tolerable Type I error rate
(significance level in the hypothesis tests); ω is the de-
sired level of statistical power (the probability of reject-
ing the null hypothesis given that it is false); n is the
average cluster size; ρ is the intra-class correlation (ICC)
coefficient, which measures the degree of similarity
among individuals inside the clusters; k is the number of
clusters (basic health units); N is the total population;
and Z1-α/2 and Zω are the standard normal percentiles.
To accommodate the clustering effect, an inflation fac-
tor was calculated using the equation DE ¼ 1þ n−1ð Þρ,
which is also commonly known as the “design effect”
[18]. This procedure increases the sample size to ac-
count for the homogeneity of the individuals inside clus-
ters larger than that expected in a design without
clusters. To obtain the adjusted sample size (n) in each
group (control and intervention), the unadjusted sample
size (m) was multiplied using the design effect (DE).
The values used in sample size calculation were α =
0.05, ω = 0.90, d = 1, n = 80.9, and N = 1320. The value for
ρ was estimated using the data of a previous project in-
volving users diagnosed with Type 2 Diabetes in a city
near Divinopolis [17]. From these data, we obtained the
value ρ = 0.008. Then, we calculated n = 65 users for each
study group. Considering a participant attrition rate of
35%, we should have, at least, 100 users in each group.
Intervention
The entire program was based on the behavior change
protocol that was validated for Brazil [19, 20]. The steps
contained in the protocol are explore the problem, iden-
tify and discuss feelings and meanings, set goals, create a
care plan to achieve the goal(s), and evaluate the experi-
ence and the plan. Together, these elements were de-
signed to facilitate and produce effective interactions
between health professionals and users.
The intervention took place over 12 months; this was
divided into the initial period when the pre-education
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tests occurred (Ti), period 0 when cycle 1 occurred (T0),
period 3 when cycle 2 occurred (T3), period 6 when
cycle 3 occurred (T6), period 12 when cycle 4 occurred
(T12), and the final period when the post-education tests
took place (Tf). Each cycle lasted three months. There-
fore, program unfolded over six distinct periods, as seen
in the model (Fig. 1).
There were 10 meetings of IG over 12 months, as de-
scribed in Fig. 1; the meetings lasted an average of 2 h
each. The meetings were divided into four cycles; the
first to the third cycle had three meetings at seven-day
intervals and three months between each cycle, and the
fourth cycle was performed in one last meeting to de-
liver test results and to complete the educational pro-
gram. During the periods between cycles, the users were
contacted monthly by telephone to be monitored with
regard to questions and motivated about the behavior
change goals that were proposed in the meetings. CG
did not attend the educational meetings, but similar to
IG, CG received the same routine care from the health
teams (conventional monitoring performed in the Basic
Health Units through clinical care).
Each health unit of IG was divided into groups with a
maximum of 10 participants, and the meetings of these
groups were held at a variety of different times and days
so that participants could choose according to their
availability resulting from work or other activities. It is
important to note that each IG comprised members of
the same team to avoid contamination. The search for
dialog and exchange of experiences in the interventions
was based on Freirean theory [15]. Home visits were
made when users were absent from group meetings, as
indicated in the protocol, in order to encourage them to
return and participate.
The first cycle, T0, was used as a baseline for the other
cycles, as it entailed three weeks of intense discussions
about the feelings and meanings of diabetes mellitus
throughout the lives of the participants, identifying their
needs and building the foundation for empowerment. At
the end of the initial cycle, respecting the protocol and
not neglecting work with feelings and meanings, it was
possible to construct the working dynamics for the other
cycles using the main topics listed by the users: physical
activity (types, frequency, stretching, proper footwear,
obesity), nutritional reeducation (frequency, amount,
composition of foods, fiber, liquids, labels), quality of life
(anxiety, stress, relaxation, influence on control of DM)
complications of DM (types, care), self-care (managing
your life, valuing your time, evaluating your choices and
consequences) and empowerment (goals for each cycle).
Fig. 1 Model of the empowerment program for self-care in diabetes mellitus
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The lead researcher guided the work in the meetings
as a facilitator and an instigator of discussions, with the
support of at least one more assistant. The problem situ-
ations that were identified were clarified by the partici-
pants, based on the life experience of those involved. At
the end of each meeting, each user set a goal to be
achieved as a way to respond to the problem that was
addressed.
Measurements
To collect data on secondary outcomes, four question-
naires involving diabetes mellitus and validated for Brazil
were used to collect the data.
The questionnaire that evaluates knowledge (DKN)
[21] contains 15 multiple-choice questions about differ-
ent aspects related to general knowledge about diabetes.
It addresses hypoglycemia, food groups and their re-
placements, cautions for diabetes complications, and
general principles of this condition. Its score can range
from 1–15 points.
The questionnaire about user attitudes (ATT) [21] is a
measure of psychological adjustment for diabetes contain-
ing 19 questions. Its score can range from 19–95 points.
The self-care questionnaire (ESM) [22] measures adher-
ence to self-care activities in users with diabetes, and con-
tains eight questions. Its score can range from 1–8 points.
The short form empowerment scale (DES) [23] was de-
signed to assess psychosocial self-sufficiency in diabetes
and contains eight items that cover the following areas:
need for change, developing a plan, overcoming obstacles,
support, dealing with emotions, self-motivation, and mak-
ing care choices for diabetes that are appropriate for the
individual's own priorities and circumstances [8]. Its score
can range from 1–5 points.
These instruments were applied to all the study partic-
ipants at two different times: at the beginning of the
study, before any educational activity, and at the end of
the study, comparing the results for Tf and Ti.
Questionnaires were also applied to collect demo-
graphic data such as age, sex, education level, occupa-
tion, and marital status, and measurements were taken
for systolic blood pressure (SBP) (mmHg), diastolic
blood pressure (DBP) (mmHg), BMI (km/m2), and
waist circumference (WC) (cm). The measures of SBP/
DBP, BMI (weight and height), and WC were obtained
twice during each data collection to obtain the mean
value in a way that reduces measurement errors. Blood
was collected to measure HbA1c (%), triglycerides
(TGL) (mg/dl), total cholesterol (TC) (mg/dl), light
density lipoprotein (LDL) (mg/dl), and high density
lipoprotein (HDL) (mg/dl) [2]. The examinations were
performed at a single laboratory both at baseline and
the end period of the study. HbA1c levels were mea-
sured using high-performance liquid chromatography
and lipid levels were measured using enzymatic
colorimetry.
Since the results were directly compared both between
groups and within each group, a cutoff value was not estab-
lished for normality in the parameters used in the study.
Analysis of the data
Statistical Package for the Social Sciences® (SPSS) soft-
ware version 20.0 was used to carry out the descriptive
analysis, along with frequency calculation and measures
of central tendency and dispersion. The Shapiro–Wilk
normality test was applied to verify the distribution of
continuous quantitative variables.
To investigate differences in categorical variables be-
tween the study groups at baseline, logistic regression
models were used considering a cluster factor nested to
the group factor. For all quantitative variables, the effect
of the experiment on a variable was defined as the differ-
ence between its values in the final period and initial
period (Δ) divided by the initial value. The values of the
effect were multiplied by 100 to transform them in per-
centage variations. To assess the difference in this effect
between the experimental groups as well as to compare
the groups at baseline, a nested ANOVA was used (clus-
ter factor nested into group factor to account for the
clusters randomization). To assess the effectiveness of
the intervention within the groups, a block factor (indi-
viduals) was added to the model, the p-values for the F
tests of ANOVA are calculated by Monte Carlo simula-
tion the ANOVA model, since these types of response
variables hardly follow the normal distribution [24]. The
simulation experiments were carried out in the R statis-
tical programming environment as well as the logistic
regression analysis [25]. For all analyses, a 95% confi-
dence level was used (p < 0.05).
Results
Following the guidelines of CONSORT [26], Fig. 2
shows a flow diagram of progress of the clusters and in-
dividuals through phases of the randomized trial. After
randomization, IG contained 162 users, and CG in-
cluded 122 users. After losses, 238 users with type 2 dia-
betes participated in the study analysis: 127 in IG and
111 in CG. In all, the study had a 16% sample loss. For
both CG and IG, there was no statistically significant dif-
ference for the variables sex, age, education level, body
mass index (BMI), and glycated hemoglobin (HbA1c)
between those users who left and those who remained in
the study (p > 0.05, Tables 3 and 4 in Appendix).
The mean age of the study population was 57.8 years
± 9.43 standard deviations (SD). The results of this study
showed that users in CG and IGs were homogeneous at
baseline with regard to the socio-demographic variables
(Table 1), biochemical and anthropometric variables,
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and secondary outcomes (Table 2). The results also
showed that the users (in control and intervention
groups) showed moderate glycemic control, and the
mean HbA1c for the 238 participants was 7.98% ± 1.95
(SD) in the initial period.
With respect to the biochemical and anthropometric
parameters, it was observed that among the participants
in IG, after intervention there was a statistically significant
reduction in values for HbA1c, TC, and LDL and DBP, and
an increase in HDL (p < 0.05). Among the individuals in
CG, in turn, after the end of the study there was a reduc-
tion in TC, and an increase in HDL and VLDL (p < 0.05).
All secondary outcomes (self-care, attitude, knowledge,
and empowerment) presented better scores after the inter-
vention with IG, but attitude and empowerment scores
also showed improvement for CG in Tf (Table 2).
The average of ΔHbA1c (percentage variation between
Tf and Ti) for the control and intervention groups were
3.93 and −5.13, respectively. The difference between the
ΔHbA1c of the two groups was considered statistically
significant (p = 0.029).
Participants in IG exhibited a greater reduction in the
percentage of HbA1c and DBP, and a greater percentage
increase in the scores for selfcare, knowledge and attitudes
in comparison to individuals in CG (p < 0.05) (Fig. 3).
Discussion
The present study showed favorable results for metabolic
control of diabetes mellitus from the empowerment
program applied over 12 months. As for the socio-
demographic data, our study had young participants, that
is, with a lower age for diabetes when compared to other
studies [5, 12, 27]. Educational levels were predominantly
Fig. 2 Diagram of the progress of clusters and individuals in the phases of the randomized trial
Table 1 Descriptive statistics for socio-demographic variables of
users with type 2 diabetes
Variable Mean ± SD or N (%) p*
CG (n = 111) IG (n = 127)
Age (Mean ± SD) 57.5 ± 9.7 58 ± 9.2 0.615
Sex (N (%))
Male 38 (34.2) 42 (33.1) 0.880
Female 73 (65.8) 85 (66.9)
Education Level (N (%))
Incomplete elementary school 73 (65.8) 90 (70.9) 0.399
Elementary school complete
to post-graduate
38 (34.2) 37 (27.1)
Marital Status (N (%))
With companion 87 (78.4) 94 (74) 0.432
Without companion 24 (21.6) 33 (26)
Occupation (N (%))
Active 55 (49.5) 55 (43.3) 0.336
Inactive 56 (50.5) 72 (56.7)
*Linear or logistic regression
CG Control group, IG Intervention group
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low, which may reflect the reality of the adult Brazilian
population. There was also a lesser presence of men, per-
haps because women value self-care more and conse-
quently were more willing to participate in the program
[28]. Most of the participants lived with a companion and
some studies show that family support is a favorable factor
for health care [11, 29].
Appropriate and continuous responses in metabolic
control can be hampered by the association of socioeco-
nomic factors such as low education levels with the diffi-
culty health services have providing education for self-
care in order to generate sustainable behavior changes
with ongoing support that can combine a healthy life-
style with emotional and physical balance [8]. Still with
regard to socio-demographic variables, it is important to
emphasize that there was homogeneity between the two
groups at the baseline.
Values for HbA1c decreased significantly between
Tf and Ti, showing that the empowerment program
had a positive effect in reducing this variable, which
is important for monitoring diabetes. Clinical trials
involving educational programs in other countries also
have shown a reduction in HbA1c [5, 12]. Notably, a
study by a group of researchers in Italy using the
same measuring instruments and protocol used in
this study also found positive results [8]. However,
prior to this study no studies were identified in Brazil
that showed a decrease in this variable after applying
an educational intervention. A study conducted in
Taiwan showed no significant changes in the mean
HbA1c associated with a self-care education program
[30]. In addition to the drop in HbA1c in IG, com-
parison of the matched differences between Tf and Ti
between the two groups (IG and CG) also showed a
significant decrease, reinforcing the favorable results
of the empowerment program.
The lipid profile and DBP also showed significant im-
provement, with reduction of TC and LDL and an in-
crease in HDL, with the exception of TGL. Control of
lipid levels and blood pressure is indispensable for users
with diabetes, considering the increased risk for cardiovas-
cular complications they face, as well as arterial insuffi-
ciency, nephropathy, and retinopathy, among other
conditions [2]. The anthropometric variables BMI and
WC, as well as SBP levels, did not show a significant
decrease. Studies also had relatively minor impacts in the
control of blood pressure and anthropometric data,
possibly due to the stringent targets established specific-
ally for diabetes in the users [8, 27].
As for self-care and knowledge about diabetes melli-
tus, IG showed significant improvements in behavior
with positive effects, such as eating habits related to re-
ducing sugar and carbohydrates, and increasing fiber,
meal frequency, and physical activity. Studies that used
Table 2 Comparison of the groups for anthropometric indicators and indicators of metabolic control, and secondary outcomes at
baseline and after intervention











HbA1c 7.9 ± 1.9 8.1 ± 2.2 0.117 8.1 ± 2.0 7.5 ± 1.7 <0.001 0.632
TC 191.9 ± 39.5 180.8 ± 45.0 <0.001 187.4 ± 39.7 171.5 ± 39.2 <0.001 0.591
HDL 41.7 ± 11.3 47.5 ± 12.5 <0.001 43.9 ± 10.3 46.2 ± 11.3 <0.001 0.148
LDL 113.8 ± 35.8 95.9 ± 36.8 0.492 105.1 ± 32.9 89.6 ± 32.4 <0.001 0.278
VLDL 36.4 ± 22.3 37.9 ± 30.4 <0.001 38.7 ± 23.7 36.1 ± 21.7 0.069 0.335
TGL 180.2 ± 110.8 189.4 ± 152.0 0.409 192.7 ± 119.3 180.8 ± 108.6 0.092 0.251
BMI 30.0 ± 6.0 29.9 ± 5.9 0.393 30.7 ± 5.8 30.5 ± 5.5 0.345 0.445
SBP 132.1 ± 16.2 135.2 ± 19.5 0.097 130.0 ± 18.3 129.1 ± 18.3 0.642 0.249
DBP 82.8 ± 13.0 83.6 ± 12.0 0.531 82.4 ± 11.9 79.3 ± 10.1 0.024 0.827
WC 96.0 ± 12.9 96.1 ± 12.9 0.197 98.2 ± 11.4 98.3 ± 11.4 0.226 0.252
SLC 3.9 ± 1.2 3.3 ± 1.1 0.820 3.4 ± 1.1 4.2 ± 1.2 <0.001 0.619
KNW 9.0 ± 2.1 9.2 ± 2.6 0.366 9.2 ± 2.3 12.6 ± 1.7 <0.001 0.603
ATT 63.1 ± 10.7 68.4 ± 11.0 <0.001 61.9 ± 9.4 78.2 ± 11.9 <0.001 0.270
EPW 3.7 ± 0.4 3.9 ± 0.5 <0.001 3.7 ± 0.4 4.1 ± 0.4 <0.001 0.817
* Nested ANOVA using a block factor for comparison before and after intra group
** Nested ANOVA for comparison between groups at baseline
CG Control Group, IG Intervention group, HbA1c Glycated hemoglobin, TC Total Cholesterol, HDL High density lipoprotein, LDL Low density lipoprotein, TGL
Triglycerides, BMI Body mass index, SBP and DBP Systolic and diastolic blood pressure, WC Waist circumference, SLC Self-care for DM2, KNW Knowledge for DM2,
ATT Attitude for DM2, EPW Empowerment for DM2
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scales for self-care and knowledge about diabetes also
showed favorable changes [12, 14, 31]. The empower-
ment program encouraged participants to make autono-
mous decisions using knowledge about their self-care
behaviors. CG presented worse scores at Tf for self-care
and knowledge of diabetes, despite receiving routine
care from their respective health units.
The results for attitude and empowerment scale for
diabetes presented better scores at the final period in
both groups, but after considering the effect of the ex-
periment (the difference between the values at Tf and
Ti) it was observed that IG had better scores than CG
for attitude. Participants with higher scores on the atti-
tude survey are theoretically more likely to accept their
diabetes, which can maximize their chances of self-care
for this condition [32].
The empowerment scale is widely used in various ran-
domized clinical studies involving self-management pro-
grams for diabetes associated with decreased HbA1c and
better scores in self-care and psychological well-being
after interventions [8, 12]. It should be noted that not all
studies indicate an association between elevating the
level of empowerment of users with diabetes and satis-
factory biochemical parameters [33].
Fig. 3 Percentual variations (Δ-delta symbol) in measurements between Tf and Ti fir IG and CG. Statistically significant differences between means
for IG and CG are marked with * (p <0.05). DG: control group; IG: intervention group; HbA1c: glycated hemoglobin; DBP: diastolic blood pressure;
SLC: self-care for type 2 diabetes; KNW; knowledge for type 2 diabetes; ATT: attitude for type 2 diabetes; EPW: empowerment for type 2 diabetes;
TC; total cholesterol; LDL: low density lipoprotien; HDL: high density lipoprotein
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The results of the instruments used in the study
showed the need for behavior change in order to reduce
HbA1c. They also helped to identify how users with dia-
betes deal with emotional and behavioral aspects linked
to this chronic condition [9].
The relevance of the results arises from the scarcity of
interventions that promote user empowerment for self-
care of diabetes in Brazil, beyond the need to incorpor-
ate more effective measures for diabetes control in the
country [8]. In this regard, it was observed that partici-
pating in the program improved biochemical parameters,
attitudes, and behaviors in the face of this condition.
Studies show that metabolic control of diabetes is the re-
sult of self-care in the user, in that the individual is able
to manage their daily control with behavior changes
based on healthy lifestyle habits. They also show that the
use of protocols to guide educational practices in a co-
responsible manner maximizes the program's activities
in developing self-care [5, 10, 34].
The homogeneity between CG and IG at baseline rein-
forced that the interventions carried out over 12 months
yielded satisfactory responses related to behavior change
and biochemical and anthropometric parameters.
Among the limitations of the study were, first, tele-
phone monitoring that may have reduced evasion in
IG, since the CG has not been monitored. At the
same time it may have encouraged the subjects to
achieve the goals they proposed. In any case, this bias
reinforces what the literature has reported throughout
history—that education also takes place through repe-
tition, in other words, this type of empowerment pro-
gram for chronic conditions needs to be perpetuated
by the health team serving the area where the users
with diabetes are located. Second, medication adjust-
ments are inevitable in managing diabetes mellitus,
which can influence the findings of the study. How-
ever, the objective of this study was not to evaluate
this relationship, in either group. Both groups re-
ceived secondary treatment from their health teams.
Third, it is known that the charisma and the skills
that researchers use to guide the groups directly in-
fluence increased or decreased user participation in
achieving goals. Even with a protocol to be followed,
it would be worthwhile in the future to compare the
results from empowerment programs led by trained
and untrained professionals.
Conclusion
The empowerment program based on individualized
goals for changing psychosocial, behavioral, and clin-
ical aspects was effective in improving self-care prac-
tices and metabolic control of diabetes mellitus in
Brazilian users.
Appendix
Table 3 Analysis of the losses in IG after randomization
Variable Mean ± SD or Median (Min-Max)
or N (%)
p
Left (n = 35) Remained (n = 127)
Age (Mean ± SD) 55.1 ± 11.97 58.1 ± 9.22 0.12*
HbA1c (Median (Min/Max)) 7.9 (5.6–12.3) 7.7 (5.3–13.5) 0.50**
IMC (Median (Min/Max)) 29.4 (21.9–41.6) 29.8 (19.1–52.4) 0.89**
Sex (N (%))
Male 15 (42.9) 42 (33.1) 0.28***
Female 20 (57.1) 85 (66.9)
Education Level (N (%))
Incomplete elementary
school




9 (25.7) 37 (29.1)
* Simple Student t-test, **Mann–Whitney, ***Chi-squared
CG: Control group; IG: Intervention group
Table 4 Analysis of the losses in CG after randomization
Variable Mean ± SD or Median (Min-Max)
or N (%)
p
Left (n = 11) Remained (n = 111)
Age (Mean ± SD) 57.2 ± 5.15 57,5 ± 9.69 0.88*
HbA1c (Median (Min/Max)) 7.2 (6.3–8.4) 7.4 (5–14.4) 0.70**
IMC (Median (Min/Max)) 29.3 (26.6–35.9) 29.4 (17.1–46.3) 0.97**
Sex (N (%))
Male 4 (36.4) 38 (34.2) 0.89***
Female 7 (63.6) 73 (65.8)
Education Level (N (%))
Incomplete elementary
school




5 (45.4) 38 (34.2)
* Simple Student t-test, **Mann–Whitney, ***Chi-squared
CG: Control group; IG: Intervention group
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Abbreviations
DM2: Type 2 diabetes mellitus; CG: Control Group; IG: Intervention group;
HbA1c: Glycated hemoglobin; TC: Total Cholesterol; HDL: High density
lipoprotein; LDL: Low density lipoprotein; TGL: Triglycerides; BMI: Body mass
index; SBP and DBP: Systolic and diastolic blood pressure; WC: Waist
circumference; SLC: Self-care for DM2; KNW: Knowledge for DM2;
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